UnknownNot Applicable

Non-invasive Absolute Intracranial Pressure Measurement in Patients With Malignant Middle Cerebral Artery Infarction for Determination of Timing to Descompressive Craniectomy.

48 participantsStarted 2018-01

Plain-language summary

This is a single centre, observational study with a medical device which has Conformité Européenne (CE) marking. The aim of the study is to demonstrate that patients with malignant middle cerebral artery infarction (M-MCA) show an increased intra-cranial pressure (ICP) compared to neurological patients without M-MCA infarction or other space-occupying indications.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient with an ischemic stroke in the internal carotid artery or middle cerebral artery territory at risk of a malignant MCA evolution, defined based on clinical presentation, clinical course (showing a progressive deterioration of conscious within the first 24-48 h), and neuroradiological findings. * Age: ≥ 18 years at admission * Informed consent obtained Exclusion Criteria: * Patients with wounds, scars including the front orbital region. * Patients with any known ocular condition that may be worsened by sustained eye pressure.

What they're measuring

non-invasive ICP) measurement im mmHg

Timeframe: 3 days

Trial details

NCT IDNCT03221959

SponsorKienzler Jenny

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2020-12

Contact for this trial

Jenny Kienzler

+41 62 838 58 72 jenny.kienzler@ksa.ch

View on ClinicalTrials.gov More Intracranial Pressure Increase trials